Prime Medicine (PRME)
Develops Prime Editing therapies for liver, lung, and partnered cell-therapy programs.
$3.30
vs last close−0.25 (−6.92%)
Something off on this page? Send us feedback.
Next report
Nov 6, 26
estimated · in 44 days
EPS estimate
−$0.23
Revenue estimate
$1.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.31−$0.40−$0.41−$0.32−$0.22−$0.28−$0.24Pending
Estimate−$0.37−$0.32−$0.36−$0.28−$0.25−$0.24−$0.26−$0.23
Surprise+16.2%−25.0%−13.9%−14.3%+12.0%−16.7%+6.7%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$2.2M$1.5M$1.1M$1.2M$842.0K$856.0K$1.2MPending
Estimate$6.8M$2.3M$2.8M$2.1M$1.3M$2.3M$2.3M$1.3M
Surprise−67.8%−37.7%−60.2%−40.3%−34.6%−63.2%−48.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.20 | — | — |
| Sep 2028 | −$0.21 | — | — |
| Jun 2028 | −$0.21 | — | — |
| Mar 2028 | −$0.21 | — | — |
| Dec 2027 | −$0.24 | — | — |
| Sep 2027 | −$0.24 | — | — |
| Jun 2027 | −$0.25 | — | — |
| Mar 2027 | −$0.26 | — | — |
| Dec 2026 | −$0.23 | — | — |
| Nov 2026 | −$0.23 | — | — |
| Aug 2026 | −$0.26 | −$0.24 | +6.7% |
| May 2026 | −$0.24 | −$0.28 | −16.7% |
| Mar 2026 | −$0.25 | −$0.22 | +12.0% |
| Nov 2025 | −$0.28 | −$0.32 | −14.3% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Jan 2021 | |||
| Dec 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.20 | — | — | $1.2M | — | — | — |
| Sep 2028 | −$0.21 | — | — | $1.2M | — | — | — |
| Jun 2028 | −$0.21 | — | — | $1.2M | — | — | — |
| Mar 2028 | −$0.21 | — | — | $1.2M | — | — | — |
| Dec 2027 | −$0.24 | — | — | $1.3M | — | — | — |
| Sep 2027 | −$0.24 | — | — | $1.3M | — | — | — |
| Jun 2027 | −$0.25 | — | — | $1.2M | — | — | — |
| Mar 2027 | −$0.26 | — | — | $1.2M | — | — | — |
| Dec 2026 | −$0.23 | — | — | $6.1M | — | — | — |
| Nov 6, 2026 | −$0.23 | — | — | $1.3M | — | — | — |
| Aug 6, 2026 | −$0.26 | −$0.24 | +6.7% | $2.3M | $1.2M | −48.7% | −4.2% |
| May 7, 2026 | −$0.24 | −$0.28 | −16.7% | $2.3M | $856.0K | −63.2% | −8.5% |
| Mar 3, 2026 | −$0.25 | −$0.22 | +12.0% | $1.3M | $842.0K | −34.6% | −9.2% |
| Nov 7, 2025 | −$0.28 | −$0.32 | −14.3% | $2.1M | $1.2M | −40.3% | −8.9% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 28, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 10, 2024 | |||||||
| Mar 1, 2024 | |||||||
| Nov 3, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Jan 1, 2021 | |||||||
| Dec 31, 2019 |